Inhibition of endogenous reverse transcriptase antagonizes human tumor growth
- 4 April 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (24) , 3923-3931
Abstract
Undifferentiated cells and embryos express high levels of endogenous non-telomerase reverse transcriptase (RT) of retroposon/retroviral origin. We previously found that RT inhibitors modulate cell growth and differentiation in several cell lines. We have now sought to establish whether high levels of RT activity are directly linked to cell transformation. To address this possibility, we have employed two different approaches to inhibit RT activity in melanoma and prostate carcinoma cell lines: pharmacological inhibition by two characterized RT inhibitors, nevirapine and efavirenz, and downregulation of expression of RT-encoding LINE-1 elements by RNA interference (RNAi). Both treatments reduced proliferation, induced morphological differentiation and reprogrammed gene expression. These features are reversible upon discontinuation of the anti-RT treatment, suggesting that RT contributes to an epigenetic level of control. Most importantly, inhibition of RT activity in vivo antagonized tumor growth in animal experiments. Moreover, pretreatment with RT inhibitors attenuated the tumorigenic phenotype of prostate carcinoma cells inoculated in nude mice. Based on these data, the endogenous RT can be regarded as an epigenetic regulator of cell differentiation and proliferation and may represent a novel target in cancer therapy.Keywords
This publication has 33 references indexed in Scilit:
- Cell Type-specific Expression of LINE-1 Open Reading Frames 1 and 2 in Fetal and Adult Human TissuesJournal of Biological Chemistry, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Human Alu element retrotransposition induced by genotoxic stressNature Genetics, 2003
- Role of endogenous reverse transcriptase in murine early embryo developmentMolecular Reproduction and Development, 2003
- A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcomaAIDS, 2003
- Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors 1 1Edited by J. KarnJournal of Molecular Biology, 2001
- Growth Inhibition by A Triple Ribozyme Targeted to Repetitive B2 TranscriptsHepatology, 1999
- Expression of Transposon LINE-1 Is Relatively Human-Specific and Function of the Transcripts May Be Proliferation-EssentialBiochemical and Biophysical Research Communications, 1998
- The expression of intracisternal A particle genes in the preimplantation mouse embryoDevelopmental Biology, 1991
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986